pREset and pREset LITE

Thrombectomy Devices

pCONus

Bifurcation Aneurysm Implant

p64

Flow Modulation Device

the first implant that can be fully deployed before detachment

pITA

First Rapid Exchange Neurovascular PTA Balloon Catheter

ARTESp shows 62.5% positive clinical outcome after 90 days

The treatment of mechanical thrombectomy represents a highly effective therapy in patients with acute ischemic stroke. This was recently proven by four randomized controlled trials in patients with a proximal large vessel occlusion. The ARTESp study, recently published by Dr. Sascha Prothmann et al., mirrors and reinforces the findings of the above mentioned trials. ARTESp is a prospective, multicenter, single-arm Post Market Clinical Follow-up study in which the efficacy, the safety and the long-term outcomes of mechanical thrombectomy using the pREset® Thrombectomy Device were evaluated.continue reading